Advertisement
Advertisement

CORT

CORT logo

Corcept Therapeutics Inc.

89.01
USD
Sponsored
+0.53
+0.60%
Jul 02, 15:15 UTC -4
Open

CORT Earnings Reports

Positive Surprise Ratio

CORT beat 26 of 42 last estimates.

62%

Next Report

Date of Next Report
Jul 29, 2026
Estimate for Q2 26 (Revenue/ EPS)
$222.79M
/
$0.00
Implied change from Q1 26 (Revenue/ EPS)
+35.10%
/
-100.00%
Implied change from Q2 25 (Revenue/ EPS)
+14.59%
/
-100.00%

Corcept Therapeutics Inc. earnings per share and revenue

On Apr 30, 2026, CORT reported earnings of -0.30 USD per share (EPS) for Q1 26, missing the estimate of -0.01 USD, resulting in a -1530.43% surprise. Revenue reached 164.90 million, compared to an expected 196.36 million, with a -16.02% difference. The market reacted with a +10.53% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 7 analysts forecast an EPS of 0.00 USD, with revenue projected to reach 222.79 million USD, implying an decrease of -100.00% EPS, and increase of 35.10% in Revenue from the last quarter.
FAQ
For Q1 2026, Corcept Therapeutics Inc. reported EPS of -$0.30, missing estimates by -1530.43%, and revenue of $164.90M, -16.02% below expectations.
The stock price moved up 10.53%, changed from $46.52 before the earnings release to $51.42 the day after.
The next earning report is scheduled for Jul 29, 2026.
Based on 7 analysts, Corcept Therapeutics Inc. is expected to report EPS of -- and revenue of $222.79M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement